Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Mark Casper, Marvell Technology's Executive Vice President and Chief Legal Officer, sold 10,000 shares of common stock on April 17, 2026, generating $1,355,000. The transaction occurred at prices between $135.00 and $136.00, with a weighted average of $135.50 per share. The sale follows a 200% gain in Marvell's stock over the past year and a cluste…
Horizon Kinetics Asset Management LLC acquired a single share of Texas Pacific Land Corp common stock on April 20, 2026, at $427.65 per share. The direct holding now stands at 3,435,500 shares, while an amended Schedule 13D filed April 13, 2026, reported beneficial ownership of 9,974,556 shares. The trade occurs as TPL trades near $439.60 with mixe…
Ganesan Satish, Senior Vice President and Chief Strategy Officer at Synaptics Inc., sold two blocks of company stock in mid-April 2026. One sale on April 20 was executed under a pre-established 10b5-1 trading plan; a separate April 17 disposition satisfied tax withholding on settled restricted stock units. The company also reported fiscal second-qu…
Lisa Bodensteiner, Synaptics' Senior Vice President, Chief Legal Officer and Corporate Secretary, sold 1,798 shares of company stock on April 20, 2026 under a pre-arranged 10b5-1 plan for about $147,200. Separately, 4,210 shares were withheld by Synaptics on April 17, 2026 to cover tax withholdings tied to RSU settlement. The company's latest quart…
Vikram Gupta, Senior Vice President & General Manager, Edge Compute & Connectivity Division and Chief Product Officer at Synaptics Inc (NASDAQ: SYNA), executed a 10b5-1 plan sale of 1,548 shares on April 20, 2026 for $125,310. Three days earlier he had 5,518 shares withheld to satisfy tax obligations tied to restricted stock units. Following these …
Ting Hock Ming, a director at Trio-Tech International (TRT), sold 5,800 shares of company common stock in transactions on April 17 and April 20, 2026, totaling $41,164. The sales, executed at prices between $7.08 and $7.13 per share, leave Mr. Ting with 148,244 shares directly held. Separately, Trio-Tech disclosed a material ransomware incident at …
Wayne Wasechek, Executive Vice President and Chief Financial Officer of Rayonier Inc. (NYSE: RYN), sold 2,920 shares on April 20, 2026, for $61,816 under a Rule 10b5-1 plan to meet tax-withholding obligations tied to equity awards. The transaction, non-discretionary by plan terms, follows a string of corporate developments including a planned rebra…
Anurag Saha, CrowdStrike's Chief Accounting Officer, sold 3,157 shares of Class A common stock on April 17, 2026, under a 10b5-1 plan for about $1.35 million. The sale followed a large RSU vesting event on April 16 and leaves Saha with 56,372 directly owned shares. Analysts from Cantor Fitzgerald, Benchmark, Piper Sandler and Stifel have all reiter…
Lori Love, a director at Bitmine Immersion Technologies, Inc. (NASDAQ: BMNR), purchased a total of $15,446 of the company's common stock in two transactions during April 2026. The purchases were executed at prices between $22.01 and $22.0466 per share and raised her direct holdings to 36,783 shares. The stock trades at $22.53, reflecting a six-mont…
MP Materials Corp. Chairman and CEO James H. Litinsky sold 290,000 shares of the company’s common stock under a pre-established Rule 10b5-1 plan, generating roughly $19.21 million. The disposals occurred in two tranches in April 2026 while the shares trade above InvestingPro’s Fair Value and after a 186% year-over-year rally. Several analysts conti…
Lee Kang Jyh, a member of Photronics Inc.'s board, sold 20,000 shares of common stock on April 16, 2026, generating $918,500 at prices between $45.80 and $46.05 per share. The transaction comes as the stock trades near its 52-week high and after Photronics reported fiscal Q1 2026 results that beat analysts' expectations. The company also announced …
Neil Blumenthal, co-chief executive officer of Warby Parker Inc. (WRBY), sold roughly $2.47 million of Class A Common Stock under a Rule 10b5-1 trading plan between April 16 and April 20, 2026. The transactions, undertaken after conversion of Class B shares into Class A shares, occurred at prices between $23.99 and $25.33 per share. The stock has r…
David Leigh Wheeler, General Counsel of Firefly Aerospace Inc. (FLY), exercised employee stock options and sold the resulting 3,766 shares on April 17, 2026. The option exercise cost $8,701 at $2.3106 per share; the subsequent sale generated $169,607 at a weighted average of $45.0366 per share, with transaction prices between $45.00 and $45.06. Bot…
Slide Insurance Holdings Chief Risk Officer Matthew Larson sold 20,000 shares of common stock in April 2026 after exercising fully vested options. The sales, executed under a 10b5-1 trading plan adopted Dec. 4, 2025, generated roughly $384,387 in proceeds. The transactions follow a strong fourth-quarter 2025 performance for the company and recent a…
Clark Joseph Gates, Senior Vice President and President of Optimized LED at Penguin Solutions, sold 5,000 shares of company stock under a pre-established Rule 10b5-1 plan on April 16, 2026, for $134,100. Days later he surrendered 2,288 shares to cover tax withholding tied to restricted stock unit vesting. Penguin Solutions reported second-quarter f…
Yap May Yee, Senior Vice President and Chief Information Officer of Jabil Inc. (NYSE: JBL), sold 1,634 shares of Jabil common stock on April 16, 2026, for a total of $501,220. The sale took place as the shares trade close to a 52-week high, and follows a quarterly financial report that exceeded management guidance midpoints and prompted several ana…
KalVista Pharmaceuticals Chief Financial Officer Brian Piekos sold 1,862 shares on April 17, 2026 in a transaction designed to cover tax withholding from recently settled restricted stock units. The sale, carried out at $20.2163 per share for a total of $37,642, was not discretionary and follows settlement of 6,250 RSUs on April 16, 2026. The compa…
Nicole Sweeny, Chief Commercial Officer of KalVista Pharmaceuticals, sold 1,862 shares of company stock on April 17, 2026, at $20.2163 per share for proceeds of $37,642. The transaction followed the April 16, 2026 vesting and settlement of 6,250 restricted stock units and was executed to satisfy tax withholding obligations rather than as a discreti…
Santiago Subotovsky, a director of Zoom Communications, sold 5,031 shares of Class A common stock on April 16, 2026, for a total of $439,286. The trades, executed under a Rule 10b5-1 plan adopted January 13, 2026, included both direct holdings and shares previously held by the Subotovsky Mann Family Trust, which now holds no Zoom stock. The company…
KalVista Pharmaceuticals Chief Executive Officer Benjamin L. Palleiko executed a sell-to-cover transaction on April 17, 2026, disposing of 9,550 shares worth $193,065 to meet tax withholding obligations tied to vested Restricted Stock Units. The RSU settlement and associated share movement occurred as the company reported robust fourth-quarter fisc…
KalVista Pharmaceuticals' Chief Medical Officer executed a tax-related stock sale worth roughly $54,300 after a tranche of restricted stock units vested. The disposition did not reflect a discretionary sale, and it follows recent corporate updates showing robust Ekterly demand, notable quarterly and annual sales, and interim pediatric trial results…
Steven D. Borges, Executive Vice President of Global Business Units at Jabil Inc. (NYSE: JBL), sold 5,126 shares of company stock on April 17, 2026, for roughly $1.63 million. The sale occurred across multiple trades, at prices between $317.50 and $317.82 and a weighted average of $317.5088 per share. Jabil recently reported a strong fiscal second …
Reddit Chief Operating Officer Jennifer L. Wong disposed of roughly $6.32 million worth of company stock on April 16, 2026, through trades carried out under a Rule 10b5-1 plan. The same day she exercised previously vested options, acquiring 39,167 Class A shares at $5.35 per share. The transactions leave Wong with just over 1.08 million shares dire…
Bicara Therapeutics Chief Executive Officer Claire Mazumdar sold 15,000 shares of company stock for $354,145 on April 20, 2026, under a prearranged Rule 10b5-1 plan. The company has reported strong cash reserves and encouraging clinical data for lead candidate ficerafusp alfa, prompting analyst attention, even as InvestingPro flags potential overva…
Broadwood Partners, L.P. increased its ownership in Insight Molecular Diagnostics (NASDAQ: IMDX) via open-market purchases totaling $652,875 between April 16 and April 20, 2026. The transactions were executed at prices spanning $3.20 to $3.99 per share. Following the buys, Broadwood Partners holds 12,114,700 shares of IMDX and reporting parties hol…
